1.Studies on the expressions and clinical significance of miRNAlet 7 and Ras in non-small cell lung cancer
Xiaomei YAN ; Chuanhai XU ; Jianyun LAN ; Xiaoou YAN ; Chenghong SHEN ; Yizhong FENG
Journal of Chinese Physician 2012;14(7):881-884,888
Objective To study the expressions of miRNAlet7 and Ras in non-small cell lung cancer ( NSCLC),and their correlations with clinicopathological features and survival time.Methods In-situ hybridization was used to detect the expression of let7,and SP immunohistochemistry to measure HMGA2 in 68 NSCLC cases ( group A) and 20 cases with normal lungs ( group B).Results The positive rate of let7 in group A was lower than that in group B (39.7% vs 63.2% ) ( P <0.05).The positive rate of Ras in group A was higher than that in group B (66.2% vs 25.0% ) ( P <0.01 ).The positive rate of let7 was not related to the age,gender,histological type,cell differentiation,and clinical stages of cancer patients(P >0.05).The positive rate of Ras was related to smoking,sex,and histological type of cancer( P <0.01 ),and was not related to cell differentiation,lymphatic metastasis,and clinical stages of cancer ( P >0.05).There was an obvious negative correlation between let7 and Ras( r =-0.627,P <0.01 ).The 2-year survival rate of let7-positive group was higher than that of the let 7-negative group ( x2 =4.84,P <0.05).No statistically significant difference was found between Ras-positive and-negative groups ( P >0.05 ).Conclusions The lower level of let7 expression,and high level of Ras expression have much to do with the carcinogenesis of NSCLC.The level of let7-positive expression is closely related to prognosis; while Ras may act in cooperativity in the occurrence and development of NSCLC.
2.Research progress on the application of eye tracking technology in neurode-generative diseases
Feng WANG ; Jiangfeng LAI ; Chenghong LAN ; Qingyun LIU ; Yi SHAO
Recent Advances in Ophthalmology 2024;44(11):908-913
In many neurodegenerative diseases,eye movement is disrupted,which is a common and early characteris-tic of neurodegenerative diseases.Characterizing eye movement is important for the diagnosis of neurodegenerative disea-ses,helping to track disease progression and response to treatment.In recent years,eye tracking technology has been ap-plied to the assessment of cognitive function in patients with neurodegenerative diseases.Compared to traditional cognitive assessment methods,the technology has higher temporal and spatial resolution for sensitive quantification.Eye tracking da-ta confirms that executive dysfunction is common in Parkinson's disease and amyotrophic lateral sclerosis,while attention deficit is a characteristic of Alzheimer's disease and multiple sclerosis.Research using eye tracking to evaluate the cogni-tive function of epilepsy patients is still in its early stages,but this method has shown advantages.In this article,the appli-cation of eye tracking technology in neurodegenerative diseases is reviewed.
3.Research progress of metabolomics in age-related macular degeneration
Feng WANG ; Chenghong LAN ; Yiling LIU ; Yi SHAO
International Eye Science 2025;25(5):760-764
Age-related macular degeneration(ARMD)is a common multifactorial disease among the elderly, which may lead to irreversible vision loss; however, the pathogenesis of ARMD is still unclear. Metabolomics is a relatively new “omics” technique that can provide qualitative and quantitative information about low molecular weight metabolites that make up biological systems, thereby revealing the physiological or pathological state of cell or tissue samples at specific time points. In recent years, increasing evidence suggests that metabolic dysfunction plays an important role in the development and progression of ARMD. Metabolic pathway dysregulation involves lipid metabolism, nucleotide metabolism, amino acid metabolism, and energy metabolism, which may play important roles in the occurrence and development of ARMD. The retina is one of the most metabolically active tissues in the human body, so using metabolomics techniques to measure molecular changes in ARMD will further enhance our understanding of the pathogenesis. This will provide important insights for the prevention and treatment of ARMD, This article reviews the application of metabolomics in ARMD.